GREM1 and breast carcinoma: Like ERRα activity, the mRNA levels of ERRα target genes, KLK3, ENO1 or TAPBPL, were also significantly elevated in GREM1-overexpressing breast cancer cells (Fig. 6b and Supplementary Fig. S8a).